The trading halt is requestedin respect of preparation and finalising the release of the European Medicines Agency Paediatric Committee Opinion adoption of the Paediatric Investigation Plan for ATL1102 for the treatment of Duchenne muscular dystrophy;
ANP Price at posting:
29.5¢ Sentiment: Buy Disclosure: Held
the release of the European Medicines Agency Paediatric Committee Opinion adoption of the Paediatric Investigation Plan for ATL1102 for the treatment of Duchenne muscular dystrophy;
